Market revenue in 2024 | USD 345.1 million |
Market revenue in 2030 | USD 548.1 million |
Growth rate | 8% (CAGR from 2025 to 2030) |
Largest segment | Glucose oxidase/glucose dehydrogenase |
Fastest growing segment | Lactate dehydrogenase |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Taq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase |
Key market players worldwide | Takara Bio Inc, Promega, Enzo Biochem Inc, Merck KGaA, Thermo Fisher Scientific Inc, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diagnostic enzymes market will help companies and investors design strategic landscapes.
Glucose oxidase/glucose dehydrogenase was the largest segment with a revenue share of 8.72% in 2024. Horizon Databook has segmented the China diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2018 to 2030.
China is expected to grow at a lucrative CAGR over the forecast period owing to increasing applications and a growing market for diagnostic enzymes. China is one of the fastest-growing markets in the region. Some of the key factors responsible for market growth in China are the rapidly aging population, increasing ease of accreditation of laboratories, growing number of laboratories, and improving medical infrastructure.
China's diagnostic enzymes market is growing, driven by the trend of personalized medicine in China. As healthcare providers move toward tailored treatment approaches, there is a rising need for precise diagnostic tests that can guide individualized therapies. Enzyme-based tests play a crucial role in this shift by providing accurate insights into patient conditions.
Horizon Databook provides a detailed overview of country-level data and insights on the China diagnostic enzymes market , including forecasts for subscribers. This country databook contains high-level insights into China diagnostic enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account